Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4703 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5308 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2017-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2019-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2019510974-A |
titleOfInvention |
Use of nucleosome-transcription factor complex for cancer detection |
abstract |
The present invention relates to the use of a tissue specific transcription factor-nucleosome adduct or a transcription cofactor-nucleosome adduct as a biomarker in biological fluid for the detection or diagnosis of cancer in a subject. The invention further relates to the use of said tissue specific transcription factor or cofactor adduct to identify the site of development of cancer in a subject. [Selected figure] Figure 1 |
priorityDate |
2016-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |